Does TOPOTECAN Cause Off label use? 390 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 390 reports of Off label use have been filed in association with TOPOTECAN (HYCAMTIN). This represents 11.0% of all adverse event reports for TOPOTECAN.
390
Reports of Off label use with TOPOTECAN
11.0%
of all TOPOTECAN reports
88
Deaths
72
Hospitalizations
How Dangerous Is Off label use From TOPOTECAN?
Of the 390 reports, 88 (22.6%) resulted in death, 72 (18.5%) required hospitalization, and 28 (7.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 390 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
Thrombocytopenia (207)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TOPOTECAN Alternatives Have Lower Off label use Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE